View All News

@BERINGEA TWITTER
MEDIA CONTACTS

 KELLY ODONNELL
Beringea LLC
+ 1 248 489 9000
 ALISON WRIGHT
Beringea LLP
+ 44 (0)20 7845 7820
Aug 09

Beringea leads £1.75m Series A into DeepCrawl

2017 BERINGEA NEWS

Marketing analytics and insights company takes funding to continue global growth as brands face mobile optimisation challenge

DeepCrawl, a leading web crawler and search marketing analytics and insights company, has taken £1.75 million in Series A funding led by growth investor Beringea. Beringea is investing £1.5 million, with the remaining funding provided by existing individual high net worth investors.


READ MORE

Aug 07

Beringea Sells Investment in MatsSoft

2017 BERINGEA NEWS UK

Beringea has announced the acquisition of portfolio company MatsSoft – a ‘low-code’ company that enables brands like Vodafone, Nationwide, ITV and the Department for Education to build web and mobile applications with minimal coding.

Founded in 2008, MatsSoft has built up an impressive roster of clients, and was named one of “The 14 Providers that Matter Most” in Forrester’s first low-code Wave Report. The deal sees Netcall – a multichannel customer engagement solutions provider – acquire 100% of the equity in MatsSoft. The acquisition will allow Netcall to extend its offering to clients in the public and private sectors, as well as access the rapidly growing low-code market, which Forrester predicts will grow to over $21billion in the next five years.


READ MORE

Jul 18

Beringea Realises Investment in Third Bridge.

2017 BERINGEA NEWS

Beringea, the growth capital investor, has realised its investment in portfolio company Third Bridge after a four-and-a-half year holding period.  The sale was part of a transaction in which IK Investment Partners acquired a minority stake in the fast-growing primary research provider.  Completion, which is subject to legal and regulatory approvals, is expected in July.


READ MORE

Jul 13

Beringea achieves 3x return in APM Healthcare exit

BERINGEA NEWS PORTFOLIO NEWS

Day Lewis Pharmacy will acquire APM Healthcare’s 18 pharmacies, extending its network to 300 pharmacies across the country

Growth capital investor Beringea today announced that APM Healthcare has been acquired by national pharmacy chain, Day Lewis Pharmacy. In the sale, Day Lewis will take over APM Healthcare’s 18 UK pharmacies, which it runs in Joint Venture Partnerships with GP Practices across the country.


READ MORE

Jul 12

Poq bags a further £3.5 million to extend its reach among enterprise retailers

BERINGEA NEWS PORTFOLIO NEWS

Retail app commerce company secures £3.5 million in funding round led by Beringea after tripling its revenue in one year

App commerce company Poq has secured £3.5 million in its latest funding round, led by growth capital investor Beringea with additional funding from Meyer Bergman and Barclays. This round brings the total amount raised by Poq so far to £7 million.

Poq provides a Software-as-a-Service platform (SaaS) that enables retailers to build engaging shopping apps for their customers. Unlike traditional agency-built apps, Poq’s service operates on its proprietary platform, ensuring that apps are refreshed in real-time with the latest updates. Retailers using Poq’s platform can access in-app data that provides insights into their customers’ shopping habits, giving them a deeper understanding of how customers use their service.


READ MORE

Jun 05

Beringea launches ProVen Legacy plc to help investors benefit from inheritance tax relief and announces its first two loans

2017 BERINGEA NEWS

ProVen Legacy plc has completed deals with healthcare marketing agency Cogora and fintech company Celoxica

Growth capital investor Beringea has launched a new lending company, ProVen Legacy plc (“ProVen Legacy”), and closed its first two deals. Healthcare media and marketing firm Cogora and fintech company Celoxica have received £500k and £250k loans respectively to support them in their next stage of growth. Both companies are existing investments of Beringea’s VCT funds; ProVen VCT and ProVen Growth & Income VCT.

ProVen Legacy is designed to help investors mitigate inheritance tax (IHT) and preserve their capital. Investors should be able to benefit from up to 100% tax relief from IHT on the value of their ProVen Legacy shares, provided that they have been held for at least two years and at the time of death. This strategy is designed to meet the conditions of Business Property Relief, a tax incentive established by the government to encourage investment into trading businesses. The investments into ProVen Legacy will be used to support growing companies across a range of industries as they enter the later stages of their scaling journeys, offering loans of up to £5m.


READ MORE

May 16

Beringea has sold a majority stake in long term investment SPC

BERINGEA NEWS

Beringea have announced that it has sold a majority stake in long term investment SPC international – a global IT hardware support company. Beringea initially invested in the company in 2003, and made two follow on investments, providing a total of just under £2.7m over five years. SPC has revenues of c.£20m and operates in five countries. Beringea will retain a 5% stake in the business going forward.


READ MORE

May 16

Edtech startup secures £4.5m funding round to fire up expansion

BERINGEA NEWS

·         Firefly Learning achieves largest early stage fundraising in Edtech sector

·         Product already used by 480 schools in 32 countries

·         Business founded by two entrepreneurs who nurtured their boyhood startup

Firefly Learning, an Edtech business dreamt up by two London school boys to help them revise for exams, has secured the biggest series A fundraising ever seen in the UK Edtech sector. The online tool, which can be used by teachers, students and parents, has raised £4.5 million from BGF Ventures and Beringea*. BGF Ventures is the leading investor, contributing £3 million.


READ MORE

Mar 28

Beringea portfolio company D3O’s gel used by NFL, U.S. & UK armed forces

2017 PORTFOLIO NEWS UK US

CNN: ‘Orange goo’ is used in armor for soldiers and football players

(CNN)Could this slimy, brightly colored orange goo be a real-life version of the “Flubber” from the 1997 film starring Robin Williams?  Not quite… But while it may look like it’s made for children, in reality it is revolutionizing the way soldiers are protected, and could radically reduce the number of head trauma injuries in football.

It’s a gel developed by UK-company D3O that acts as both a liquid and a solid. When handled slowly the goo is soft and flexible but the moment it receives an impact, it hardens. It’s all thanks to the gel’s shock-absorbing properties.  Read more.

Feb 23

beringea portfolio company Blis Integrates World’s Largest Beacon Network, Empowering Brands To Improve Attribution and Targeting

2017 PORTFOLIO NEWS US and UK

Blis, the global pioneer in advanced location data technology, is partnering with Unacast, the world’s largest network of proximity data and the creators of the Real World Graph™, to provide brands greater understanding of who consumers are and how they behave both on- and offline along the path to purchase. These insights will improve attribution and empower brands to successfully target consumers with the most accurate and detailed location data available on the market.


READ MORE

Disclaimer

The information on this website is issued in the United Kingdom by Beringea, a company authorised and regulated by the Financial Conduct Authority. It is designed for the information of readers only and does not constitute or form part of any offer or invitation to purchase, subscribe for or dispose of securities, nor shall it or any part of it, form the basis of or be relied upon in connection with any contract therefor. It does not provide financial information on any of Beringea's companies or any company in which any of them has invested.

Services provided by Beringea's non-UK office are not subject to UK regulation. In the United States of America, Beringea operates as an SEC-registered investment advisor, Beringea, LLC.

This website shall not constitute an offer to sell or the solicitation of an offer to purchase shares or interests in any of the funds in any jurisdiction. Such an offer may only be made by the prospectus or private placement memorandum for the relevant funds, and only to investors who meet certain eligibility requirements.

It is a condition of accessing each page of this website, that the entrant confirms that he/she has read and understood the above notes and thereby accepts the basis upon which access is permitted. Full Disclaimer

Close
Back to links